Inhibikase Therapeutics logo
Inhibikase Therapeutics IKT
$ 3.14 -1.86%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Inhibikase Therapeutics P/CF Ratio 2011-2024 | IKT

Annual P/CF Ratio Inhibikase Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-0.678 -0.187 -1.35 -48.4 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-0.187 -48.4 -12.7